1,3-diaryl cyclopentanes and derivatives thereof as PAF antagonists

摘要

Novel 1,3-diaryl cyclopentanes of the following general formula were prepared. <IMAGE> (I) These compounds were found to have potent and specific PAF (Platelet Activating Factor) antagonistic activities and as such useful in the treatment or amelioration of various diseases or disorders mediate by the PAF, for example, hypotension, inflammation, nephritis, stroke and other cardiovascular disorders, asthma, allergic and skin diseases, peptic or stomach ulcer, shock, lung edema, psoriasis, adult respiratory distress syndrome, pain including dental pain, and aggregation of platelets.